ONVIF Reactivates Dahua and Hikvision As US Adjusts Sanctions Terms
ONVIF is fully reactivating Dahua and Hikvision as the US government has adjusted the terms of its Entity List sanctions.
In 2019, ONVIF suspended Dahua and Hikvision following US government sanctions for human rights abuses.
In this note, we examine what changed and how this impacts Dahua and Hikvision.
US ********* ***** *******
** ********* *, *** ** ********** ** ********'******* ** ******** *** ********(***), ***** ******** *** ****** ****,*********** *** ********** ******* ********** ********* "when **** ******* ****** ** *** context ** * *********-******* ********":
********* ************* ** ********* **** ******* **-****** technology ** ****** ******** **** *********, Dahua, *** ******. **** **** ********** the ******* ** ** ***** ** participate ** ************* ********* ************* **** those ********* **** **** **.
**** ****** ******** **** ** ********* would ** **** *** **** *** many ********* ****** **** ****** *** joined, *** ** **** ** ********* the ****** ****. ** ********, ** a**** **** ******,*** ******* *** ******* ** **** US ********** ** ****** *** *********-******* in ***** ** "******** ** ************* leadership".
**** **********, ******** ** ******* *** corporations**** ** ******** ********************* ******** ***************** **** ****** ***** ***********-****** *****, *** **** ******, *** this *** ******* ** *** ********* 9th **** *** ******.
ONVIF ***********
***** **** **** **** **** ****** in *** ***** ***** *** ****** List ********* *** "*********** ***** ** ONVIF" ********* ********** ********:
***** ********** ** **** ** *** company ** ******** ***** ** *** observer, ****, ********** *********, ************, ** full ********** *****. ********* ********* ****, changes ** ** *** ***** ********* on *** *.*. ********** ** ********, Bureau ** ******** *** ********, ****** Administration *********** ****** ****to *********** ***** ** *****. This includes participating in working groups and committees and ********** ******** ** *** ***** ********** ******* program. [emphasis added]
*** **** **** ***** ******** * product **** ********* ** **** **** 2020, ********* ** * ****** *******'* ********** ******** ****:
*** *****, *** ****** *****-******** ******* is **** **** ****:
******** ********* *** ********* ***** ** *** ****** **** in ******* ****,***** ********** ***** ** ********* *** ***** confirming ******** *** ** * '***** period' ****** *** *********' ****** ** the ***** **** **** ***** ********** in ***** ****.
Impact ********
*** **** ****** ** **** ***** and ********* *** *** ****** ***** products *** ******** ***** ***********, ********* that **** **** *** **** ** do **** *** **** * *****.
********* *** ***** **** ** ******* its ******* ****** ******** ** ******* parts ** *** *****, *** *******,********* **** * $** ******* ******* government **** **** ***** *********** ***.
**** ****** **** ***** *** ********* for ******** ********* ***** ***********.
*******, ** *** **** * ***** far **** ***** ************ ******** *** transitioned ** *** ***** ***** ***** is ********* *** ****. **** **** update ** *** **** ********* *** Dahua ***** **-********** ******** ** *****.
Other ** ********** *******: *** *** ****** ****
**** ********** * **** **** ** the ** ********** ******** ************ ** Hikvision *** *****. *******, **** ** in ** ******** ****** ** * broader ****** ****** ****** **** * deliberate ** ********* ******* *** *********.
********* *** ***** ****** ******** ** serious ******** ************, ************ *********** *** ******** **** ***** *** ********* *** Dahua ********* ************** ** **** ***** between *** *** ******** **, ****.
Magnitsky **** *******
********* *** ***** *** **** ** risk ** ***** ***** ** ********* that *** **** ******* **** *** Entity ****, ******* ********* ********* ***** would *** *** ************ ******* *** companies *** ** "*******" (****** *** companies), *.*. ********** ********* *** *** Dahua *** *** ****.
***** ***** ** ** ********* **** the ** **** ****** ********* *********, a ******* ** ********** ******* ****** *** ****** *********, ********* ********* ** ****** ******** ** ** ******** *** ** dollar ******** **** ** ****.
Hikvision, ***** ** ********
**** ***** *** ********* *** ***** reaction ** *****'* ************ *** ******* they **** ******* ********** ******** *** conformance. ** ***, **** **** *** responded; ** **** **, ** **** update.
"...******* ***** ****..." ?
*** ******* ** ****** *********. ****** ******* ********,******* ***** ***** *** ****** "**** an ****** ***** **** ** *** good ***** ** ***** * ***** rule ******* ***** ********** * ******** rule". "*****" ***** *** **** "******* effective *********** **** ***********". "*******" ***** public ******** *** ************ ******** ** the ****, ** **** **** ***** November *:
*** ****** *** ***** *** **** "if ********* ** *** ****** ********".
***** *** ********* ********* *** ****** our ******** **** ***** **** ** seemingly ****** *******:
**** ** ******** *** *** ** be ******* ****** **** **** ********* that ** ********* ** ***** ** Hikvision?
** ****, **'* **** * ****** of **** ********* ** ********.
** ******* **** *** ** **** like **** ** ******* **** ****, please, ** **** ***** ***** *** will **** ***** *****
****
******, * ** ***** ********. ***** and ********* ****** ********* ****** **** of ***** "**** ****" ** ******'* it **** ***** ** ***** **** or ********* *** ********. ***** **** logic, *** ** *** **** **** what ** ************** **** **** ****?
** ***** ** ***** *** ********* people *** ***** ************. **** ***'* really ***** **** ** "**** ****", they ** *** **** **** *** news ** ******** ** ***** ********* interests.
*** *** ****.
** ***'** ********* ********* **** **** is **** ************** ** *** ***** hand ***'** ** **** ** *********** that **** ** ****** *** ***** your ******* *** ******** **
** ***'** ********* ********* ****, *** know **** ***'** **** *** ***** to ******* ** ********** **** ** likes.
* ******* *** * ****** * believe, ** ******** **** ** *** first ******* ********* ****** **** ***** and **** ** *** ****** ******* it's ****** ** *****.
********* ****** *** ********* *** **** not *** ****** ***'* ********* **. In ** *******.
*** *** **** **** ******
****
*** **** **** ***'** **** *** first ** ******* ** ********** **** of *****.
* ** ********* ***% ******* **** dozens ** ***** *** ********* ********* and ******* *** ****** *** **** post. ** **** *** **** **** news *** ***** **** **** ** grant *********** ** *********** ** ****?
**** ****, * ** **** **** it, ** ****** ** ***** **** the ********* ** *** ** ****** by ***** ***** **** *** **** but ******** ********. ** **** ******, Verkada ********* *** *** ****.
*** **** ** **** ***** **** comments **** ** ***** *** *** from **** * ***** ***'* **** the ******** ***'** ****** ** **** the ***** ******* **** ***'** **** it ** **** **** **** *****.
* ***** *** ******* ******** *** Onvif **-*********** *** *******, **** **** the *** **** ******** *** ******* against * ****** **** *******, *** name ** ********* * *** ****** not *** ******* ****.
*** *** *** *** * *** more *****. ****** **** **** * big ***. "****** *** "*** ******* use" ********
********** * ***** **** *** *********, crippling ******** ******* ** ********** ******** like *** *** ******** *************. *** opening ** ** *** ***** **** may **** *** *** ******. ** long ** *** ****** ******* ** the ***** ******** ****, ** *** be "******" **********.
******....
***** ******** *** ******** *** **** do *** ******** ** **** *******, the ********** *** **** ********. **** does * *** **** ** **** area. ************ **** **** ***** *****'* tools *** ****** * ****** ** it's *********** ** *** ********.
* **** **** * ***** ****** of ******* **** **** *** ***** but ** *** ****** ****, *** tests ** ***,****** ****** *** ****** effects, **** *** *** *** * have **** ********* *** **** ***** for *** ****** **** ** *** test. (*'*** ** ***** *** **** random ****** ****)
***** *** ***** * *** **** in ****** ***** *** ** ** far **** *******, *** **** **** has ********. * ** ***** ** the ****** **** *** ******** *** qualifying ******* *** **** ***** ******** as ** ** ******* ** ******.
******: ***** ********* ** ****, ******** us ** "********** ********* **** ******* Chinese *********" *** ******** *** *** "has ********* ** ********":
**** ***** **** **** ****** *** facts ** *** **** *** ******* its ********** ********* **** ******* ******* companies. *** *** ** ** *** middle ** * **** ****** ******* and *** ********* ** ********, *** IPVM ****** ** ** '******** *** ban' ** ** *** ******** ******* to ****. *** ** ***** **** Dahua ** ******* '** ****' ** a ********* ******** **** *** ******* has ****** *** **** ****** ******* a ********** **** ** **** ************* 'reporting' *** ****** ********** ** *** subject ** *** *******.
*******, **** ********** *** "******** *** ban" ** * ********* ** ***** legislation ****** ** ********* ***** **** year, ********* ********* ***. *** ***, ***** *** ****** on ******** **, ****, ******** *** FCC "** ****** ****** ** *******" Hikvision, *****, ******, ******, *** *** applications *** *** ********* ************* "*** later **** *** ****" **** **** of ********* *.*. ** ******** **, 2022:
************, **** ********** *** **** ** Magnitsky ***** ****** ********* ** ************ because ** *****'********* ** ***** ****** ************ ********* ******** ******** ** *** ******,*** **** ******* "******* *********".
*** *** ** ** *** ****** of * **** ****** ******* *** has ********* ** ********
*'* **% **** **** ****** ***** or ********* *** **** **** ****** before. "** ****'* ******** ***, ********* it ***** *** ******". ** ***** be *** ** ****** *** *** standard ********* *** **** *** **** press ******* ********* ** ***** ********* it ****. ** ***** **** **** repeat ********** * ***. *** *******, "bias ******* ******* *********" - ****** sure ****'* *** ** ***** ******** counterarguments.
**** **** **** *** ****** ********* Act ****** *** *****,********* ****"******* ******** *** ****** ** ***." The ****** **** ** ** **** it *********** *** **** ***.
****'* *** ******* **** ***** ** mind *** **.
******* ** ***** **** ** ******* this ***** *** **** *** *** ban ** *******? *** ********? ** is ** **** ***? ******.
******: ***** *** ********* **** ********* over *,*** ******** *** ******** ***** ONVIF *********** ****. **'** ******** **** in * ********** ****:********* *** ***** ********* ********* ** Products *** ***** *********** ***** *************
***'* *** ******** *** *** *** Ban ******** **, **** *** ****?